Cardinal Health says it plans to expand and restructure several of
its facilities around the world after what it describes as
'heightened customer demand for clinical supply services, such as
design, packaging, labelling, storage...
A new Sino-American joint venture for manufacturing
pharmaceuticals, HBBenda, has started operations in Guangshui,
China, after being granted Good Manufacturing Practice (GMP)
approval.
